ScholarIQanswers from OpenAlex & ORCID
D. Tomaras
ResearcherPublications, citations & collaboration network
D. Tomaras is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does D. Tomaras have?
ScholarIQindexed works
D. Tomaras has 27 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does D. Tomaras have?
ScholarIQcitation count
D. Tomaras has 66 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of D. Tomaras?
ScholarIQh-index
D. Tomaras has an h-index of 4 in OpenAlex.
What is the i10-index of D. Tomaras?
ScholarIQi10-index
D. Tomaras has an i10-index of 2 in OpenAlex.
What is the OpenAlex record for D. Tomaras?
ScholarIQopenalex
The OpenAlex for D. Tomaras is on the source record.
What are the most-cited papers on D. Tomaras?
ScholarIQmost cited works
Non-small cell lung cancer with <i>EGFR</i> exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes
C.S. Kwon, Huamao Mark Lin, Victoria Crossland, Eric N. Churchill, Eileen Curran, Anna Forsythe, D. Tomaras, Sai‐Hong Ignatius Ou
Health-Related Quality of Life and Utility Outcomes with Selinexor in Relapsed/refractory Diffuse Large B-Cell Lymphoma
Jatin J. Shah, Sharon Shacham, Michael Kauffman, Patrick Daniele, D. Tomaras, Gabriel Tremblay, Olivier Casasnovas, Marie Maerevoet, Josée M. Zijlstra, George Follows, Joost S.P. Vermaat, Nagesh Kalakonda, André Goy, Sylvain Choquet, Éric Van Den Neste, Brian T. Hill, Catherine Thiéblemont, Federica Cavallo, Fátima De la Cruz, John Kuruvilla, Nada Hamad, Réda Bouabdallah, Ulrich Jäger, Paolo F. Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan‐Manuel Sancho, Michael Schuster, Miklós Egyed, Fritz Offner, T. Vasilakopoulos, Priyanka Samal, Ágnes Nagy, Matthew Ku, Miguel Canales
1362P Clinical and real-world outcomes in patients with epidermal growth factor receptor (EGFR) exon 20 insertions in non-small cell lung cancer (NSCLC): A meta-analysis
D. Tomaras, Hongcao Lin, Anna Forsythe, Victoria Crossland, S-H.I. Ou
Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons
Gabriel Tremblay, D. Tomaras, E Strati, Anna Forsythe
Comparing Costs and Consequences of Eltrombopag Plus IST Versus IST Alone for First-Line Treatment in Severe Aplastic Anemia: Results from a Responder Analysis
Gabriel Tremblay, Qayyim Said, Beilei Cai, Shan Ashton Garib, D. Tomaras, Anna Forsythe, Anuja Roy